Table 2.

Patients' clinical characteristics. IHC, immunohistochemistry; ER, estrogen receptor; PgR, progesterone receptor; N/A, not available.

Patient ID	HER2 IHC	HER2 FISH	ER	PgR	Treatment
BC patient 1	1+/2+	2.2	+	-	anti HER2 therapy (trastuzumab)
BC patient 2	0	N/A	-	-	chemotherapy (ixabepilone)
BC patient 3	2+	1.6	+	+	chemotherapy (paclitaxel)
BC patient 4	1+	N/A	+	+	biological/hormonal therapy (denosumab/letrozole)
BC patient 5	2+	1.1	-	-	chemotherapy (anthracycline)
GC patient 1	0	N/A	N/A	N/A	chemotherapy (cabazitaxel)
GC patient 2	3+	3.4	N/A	N/A	chemotherapy (cabazitaxel)